BioWorld MedTech

Nov. 7, 2011

NewCo on the Block: CerviLenz offers screening tool for preterm birth risk

CerviLenz (Chagrin Falls, Ohio), a woman's health device company in the Cleveland area, has recently bumped its Series A round of investment up to $8.35 million, thanks to a recent tranche of funding from existing investors. Read More

Report from Europe: Ziehm Imaging reports the opening of French sales office

Spinal USA continues down path of growth with 2 recent approvals

Washington roundup: Industry urges CMS to revisit criteria for pass-through codes

Deals roundup: Siemens to acquire HIE developer MobileMD

Agreements/contracts: Bluewater enters western distribution with SurgLine

MDD's Fast Facts

NASS notebook: Medtronic Spinal launches T2 Altitude at NASS conference

Med-Tech Notes: GE Capital reports $5B in healthcare financing

Financings roundup: Tenet launches tender offer for 9% senior notes due 2015

HIT roundup: Nortec to support health IT in underserved communities

Med-Tech Notes: Study: no link between diabetes and kidney stones

Med-Tech Notes: U of Iowa to use GE 7T MRI for brain research

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...